Chenyang Shi

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 6

Top Topics

Cross Sectional

Metabolic Syndrome

Top Venues

Diabetes, obesity & metabolism

Evidence-based complementary and alternative medicine : eCAM

This page only lists publications with an associated author ORCID identifier.

Publications

Chenyang Shi, Yijiong Tan, Shanshan Hu, Yingyi Qin, Yuanjun Tang, Yufan Wang, Guorong Fan
Effectiveness and safety of once-weekly subcutaneous semaglutide versus other glucose-lowering agents in real-world patients with type 2 diabetes: A retrospective, observational post-marketing study. Diabetes, obesity & metabolism 26 (6) (2024)
Shanshan Hu, Chenyang Shi, Yuhang Ma, Shuowen Wang, Shengying Gu, Chendong Qi, Guorong Fan
Cost-utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide. Diabetes, obesity & metabolism (2024)
Chenyang Shi, Yijiong Tan, Shanshan Hu, Yingyi Qin, Yuanjun Tang, Yufan Wang, Guorong Fan
Effectiveness and safety of once-weekly subcutaneous semaglutide versus other glucose-lowering agents in real-world patients with type 2 diabetes: A retrospective, observational post-marketing study. Diabetes, obesity & metabolism (2024)
Shanshan Hu, Chenyang Shi, Yuhang Ma, Shuowen Wang, Shengying Gu, Chendong Qi, Guorong Fan
Cost-utility analysis and drug pricing for tirzepatide for type 2 diabetes in the Chinese market compared with semaglutide. Diabetes, obesity & metabolism 26 (8) (2024)
Chenyang Shi, Yijiong Tan, Shanshan Hu, Yingyi Qin, Yuanjun Tang, Yufan Wang, Guorong Fan
Effectiveness and safety of once-weekly subcutaneous semaglutide versus other glucose-lowering agents in real-world patients with type 2 diabetes: A retrospective, observational post-marketing study. Diabetes, obesity & metabolism 26 (6) (2024)
Qin Li, Dilnur Tursun, Chenyang Shi, Merhaba Heyrulla, Xinyue Zhang, Weijun Yang
Ziziphora clinopodioides Flavonoids Protect Myocardial Cell Damage from Myocardial Ischemia-Reperfusion Injury. Evidence-based complementary and alternative medicine : eCAM 2018 (2018)